U.S. Senators Michael Bennet (D-Colo.), Orrin Hatch (R-Utah) and Richard Burr (R-N.C.) introduced a bipartisan bill that would expedite FDA approval and provide more flexibility when a drug or treatment shows dramatic responses early in development, while still ensuring drug safety and efficacy.
Read the full report in Becker’s Hospital Review on the Advancing Breakthrough Therapies for Patients Act.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
